Cardiovascular risk factors control according to diabetes status and prior cardiovascular events in patients managed in different settings-Reference-Cited by-同舟云学术

Cardiovascular risk factors control according to diabetes status and prior cardiovascular events in patients managed in different settings

Published:2020-10 Issue: Volume:168 Page:108370
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Vaccaro Olga,Vitale Marilena,Costanzo Simona,Masulli Maria,Riccardi Gabriele,De Curtis Amalia,Donati Maria Benedetta,Rivellese Angela Albarosa,de Gaetano Giovanni,Iacoviello Licia

Funder

Italian Medicines Agency (AIFA) within the Independent Drug Research Program

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data;Gregg;Lancet,2018

2. Cardiovascular disease in Europe: epidemiological update 2016;Townsend;Eur Heart J,2016

3. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabet Care,1993

4. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial;Vaccaro;Arch Intern Med,2004

5. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes;Rawshani;N Engl J Med,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study;Thrombosis Journal;2022-11-21

2. Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population;Frontiers in Endocrinology;2022-08-17